BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 36253536)

  • 1. Targeting the gut microbiota for cancer therapy.
    Fernandes MR; Aggarwal P; Costa RGF; Cole AM; Trinchieri G
    Nat Rev Cancer; 2022 Dec; 22(12):703-722. PubMed ID: 36253536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota: a potential target for improved cancer therapy.
    Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota transplantation: Targeting cancer treatment.
    Wu X; Zhang T; Chen X; Ji G; Zhang F
    Cancer Lett; 2019 Jun; 452():144-151. PubMed ID: 30905818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
    McQuade JL; Ologun GO; Arora R; Wargo JA
    Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy.
    Oh M; Zhang L
    Sci Rep; 2023 Mar; 13(1):4599. PubMed ID: 36944780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
    Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
    Front Immunol; 2022; 13():949490. PubMed ID: 36177041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy.
    Kang X; Lau HC; Yu J
    Cell Rep Med; 2024 Apr; 5(4):101478. PubMed ID: 38631285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy.
    Qi X; Liu Y; Hussein S; Choi G; Kimchi ET; Staveley-O'Carroll KF; Li G
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome bacterial influencers of host immunity and response to immunotherapy.
    Yousefi Y; Baines KJ; Maleki Vareki S
    Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the microbiota in response to and recovery from cancer therapy.
    Blake SJ; Wolf Y; Boursi B; Lynn DJ
    Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving ICI outcomes with a little help from my microbial friends.
    Rebeck ON; Dantas G; Schwartz DJ
    Cell Host Microbe; 2021 Feb; 29(2):155-157. PubMed ID: 33571442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of fecal microbiota transplantation in oncology.
    Lythgoe MP; Ghani R; Mullish BH; Marchesi JR; Krell J
    Trends Microbiol; 2022 Jan; 30(1):10-12. PubMed ID: 34711461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.